WebAug 24, 2024 · Serious side effects of Mycophenolic Acid include: hives. difficult breathing. swelling of the face, lips, tongue, or throat. fever, swollen glands, painful mouth sores, cold or flu symptoms, headache, and ear pain. stomach pain, vomiting, diarrhea, and weight loss. weakness on one side of your body, loss of muscle control. WebMycophenolate mofetil is an immunosuppressant approved for to prevent rejection of solid organ (kidney, liver, heart) transplants. Off-label use of mycophenolate mofetil is widespread in dermatology. Vitiligo, small vessel vasculitis, lichen planus and its variants, erythema multiforme, pyoderma gangrenosum, granulomatosis with polyangiitis ...
Mycophenolic acid IV C22H28O6 - PubChem
WebFeb 1, 2024 · The recommended dose of Myfortic in conversion (at least 6 months post-transplant) pediatric patients age 5 years and older is 400 mg/m 2 body surface area (BSA) administered twice daily (up to a maximum dose of 720 … WebMMF and mycophenolic acid (MPA) are likely to be equivalent in inducing improvement with 1440 to 2160 mg total daily dose of MPA roughly equivalent to 2000 to 3000 mg total daily dose of MMF. MMF 1 to 2 g/day PO is a recommended option for maintenance therapy for those who respond to induction therapy. cao projectinrichting
Mycophenolic acid Uses, Side Effects & Warnings - Drugs.com
WebDec 15, 2002 · Infusions, Intravenous Mycophenolic Acid / analogs & derivatives Mycophenolic Acid / analysis* WebThe aim of this prospective study was to characterize the multiple-dose pharmacokinetics of mycophenolic acid (MPA) after administration of a 3-hour intravenous (IV) infusion of … WebA pivotal, 12-month, phase III, randomized, multicenter, double-blind, double-dummy, parallel group study investigated whether stable renal transplant patients can be converted from MMF to EC-MPS therapy without compromising tolerability or efficacy. british gas free phone no